Alerts

The Federal Circuit held that the district court erred by precluding plaintiffs from pursuing unjust enrichment damages for trade secret misappropriation claims.

On June 4, US Representatives Jay Obernolte (R-Calif.) and Lori Trahan (D-Mass.) released a discussion draft of the bipartisan Great American AI Act of 2026 (GAAIA), which would establish a framework regulating artificial intelligence (AI) at the federal level.

Headlines that Matter for Companies and Executives in Regulated Industries

Ex parte reexamination has recently overtaken inter partes reviews (IPRs) in terms of popularity. Petitions for IPRs have fallen dramatically since late 2025, with only 15 petitions filed in April of this year.

On June 10, the US Food and Drug Administration (FDA) issued a final administrative order adding bemotrizinol to the list of permissible sunscreen active ingredients in the United States – the first new sunscreen active added in 26 years.

The US House of Representatives has passed the Faster Labor Contracts Act (H.R. 5408) (FLCA), a bill that would fundamentally reshape how employers negotiate first collective bargaining agreements with newly certified unions.

On June 2, the US Food and Drug Administration (FDA) released a new draft guidance called “Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing.”

State policymakers are recalibrating how they regulate and incentivize data center development.

Earlier this year, we flagged the growing momentum behind state efforts to regulate dynamic and surveillance pricing.

The Federal Aviation Administration (FAA) and US Department of Defense have stalled project reviews.

The 2027 DC budget would deliver significant new funding, programs, and policy changes to rental housing across the District of Columbia, affecting all parties involved, like tenants, landlords, and developers.

On June 8, the California State Senate adopted Senate Resolution (SR) 104, a measure expressing support for targeting the biological mechanisms of aging as a strategy to prevent and delay chronic disease.

On May 28, the US Supreme Court issued a unanimous decision in Flowers Foods, Inc. v. Brock, holding that a worker who transports goods on an intrastate leg of an interstate journey may qualify for the Federal Arbitration Act’s (FAA) transportation-worker exemption under Section 1 — even if that worker never crosses state lines and never interacts with a vehicle that does.

US alcohol importers, and alcohol suppliers that rely on imported ingredients or raw materials to produce their products, have been on a rollercoaster during President Trump’s second term trying to keep up with the Administration’s tariff policy.

The 2027 DC budget proposes substantial investments in health care access, behavioral health services, and public health infrastructure across the District of Columbia. Nearly four in 10 DC residents depend on Medicaid, the Basic Health Plan, or the locally funded Alliance program for coverage.

On June 3, the US Food and Drug Administration (FDA) released a revised draft guidance on what drug and device manufacturers can say to health insurers, pharmacy benefit managers (PBMs), formulary committees, and similar organizations about their products.

The 2027 DC budget would make sweeping investments in education across the District of Columbia, from pre-kindergarten through higher education and adult literacy. The budget supports nearly 100,000 public and public charter school students, increases per-student funding, restores critical childcare programs at risk of deep cuts, and expands career and technical education.

The 2026 legislative cycle reveals that state privacy law is diverging along partisan lines. Red-state legislatures are pursuing frameworks that retain the Virginia architecture while easing compliance burdens through broader exemptions, narrower sale definitions, permanent cure periods, and fewer assessment requirements. Blue states are moving in the opposite direction, expanding sensitive-data categories, imposing new technology-specific obligations, and broadening applicability.

On June 4, the US Supreme Court issued a unanimous decision authored by Justice Ketanji Brown Jackson in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24–889, delivering a significant win for generic pharmaceutical manufacturers seeking US Food and Drug Administration (FDA) approval for drugs with multiple indications.

On June 2, President Trump signed an executive order (EO) entitled “Promoting Advanced Artificial Intelligence Innovation and Security” that establishes new federal cybersecurity directives, creates a voluntary framework for collaboration with artificial intelligence (AI) developers on frontier models, and signals increased focus on criminal enforcement against AI-enabled cyberattacks. 

The Fourth Appellate District’s June 2 decision in Tate Road Solar 1, LLC v. County of Winnebago held that Illinois courts cannot compel counties to issue permits when solar projects meet statewide standards for solar siting under 55 ILCS 5/5-12020. 

Headlines that Matter for Companies and Executives in Regulated Industries

On March 13, President Trump signed an executive order (EO) titled “Ensuring Truthful Advertising of Products Claiming to be Made in America,” directing the Federal Trade Commission (FTC) to prioritize enforcement against false or unsubstantiated “Made in USA” and similar American-origin claims.

The US Departments of Treasury, Labor, and Health and Human Services have issued a sweeping final rule (CMS-9897-F) implementing significant changes to the Federal Independent Dispute Resolution (IDR) process established under the No Surprises Act (NSA).

On June 3, President Trump signed an executive order (EO) titled “Strengthening Customs Enforcement” that does not impose a single new tariff yet may prove to be one of the most consequential trade actions of the year for importers.